T1	PROC 65 72	Asepsia
#1	AnnotatorNotes T1	C0003974; Asepsis; Therapeutic or Preventive Procedure
T2	ANAT 73 80	cutánea
#2	AnnotatorNotes T2	C0011646; Dermis; Tissue | C1123023; Skin; Body System
T3	CHEM 84 96	clorhexidina
#3	AnnotatorNotes T3	C0008196; chlorhexidine; Organic Chemical · Pharmacologic Substance
T4	CHEM 121 133	clorhexidina
#4	AnnotatorNotes T4	C0008196; chlorhexidine; Organic Chemical · Pharmacologic Substance
T5	PROC 154 164	prevención
#5	AnnotatorNotes T5	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T6	CHEM 102 109	alcohol
#6	AnnotatorNotes T6	C0001962; ethanol; Organic Chemical · Pharmacologic Substance
T7	PROC 765 789	consentimiento informado
#7	AnnotatorNotes T7	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T8	DISO 542 545	BRC
#8	AnnotatorNotes T8	C1328352; Catheter bacteraemia; Disease or Syndrome
T9	PROC 996 1010	Uso de catéter
T10	CHEM 353 365	clorhexidina
#9	AnnotatorNotes T10	C0008196; chlorhexidine; Organic Chemical · Pharmacologic Substance
T11	PROC 386 396	prevención
#10	AnnotatorNotes T11	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T12	DISO 505 540	Bacteriemia relacionada con catéter
T13	PROC 585 602	ingresados en UCI
#11	AnnotatorNotes T13	C5419131; Intensive Care Unit Stay; Health Care Activity
T14	DISO 834 841	alergia
#12	AnnotatorNotes T14	C1527304; Allergic Reaction; Pathologic Function
T15	CHEM 856 868	clorhexidina
#13	AnnotatorNotes T15	C0008196; chlorhexidine; Organic Chemical · Pharmacologic Substance
T16	CHEM 873 893	alcohol isopropílico
#14	AnnotatorNotes T16	C0022237; Isopropyl Alcohol; Organic Chemical · Pharmacologic Substance
T17	PROC 985 992	ingreso
#15	AnnotatorNotes T17	C0021629; Institutionalization; Health Care Activity | C0184666; Hospital admission; Health Care Activity
T18	DISO 819 831	Intolerancia
#16	AnnotatorNotes T18	C0277585; Intolerance to drug; Pathologic Function
T19	DISO 168 205	bacteriemias relacionadas con catéter
#17	AnnotatorNotes T19	C1328352; Catheter bacteraemia; Disease or Syndrome
T20	CHEM 316 328	clorhexidina
#18	AnnotatorNotes T20	C0008196; chlorhexidine; Organic Chemical · Pharmacologic Substance
T21	DISO 400 437	bacteriemias relacionadas con catéter
#19	AnnotatorNotes T21	C1328352; Catheter bacteraemia; Disease or Syndrome
T23	DISO 955 968	fallecimiento
#20	AnnotatorNotes T23	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T24	CHEM 334 341	alcohol
#21	AnnotatorNotes T24	C0001962; ethanol; Organic Chemical · Pharmacologic Substance
T25	PROC 251 288	Ensayo Clínico Fase IV de comparación
T26	PROC 297 304	Asepsia
#22	AnnotatorNotes T26	C0003974; Asepsis; Therapeutic or Preventive Procedure
T27	ANAT 305 312	cutánea
#23	AnnotatorNotes T27	C0011646; Dermis; Tissue | C1123023; Skin; Body System
T28	Date 13 17	2017
T29	DEVI 198 205	catéter
#24	AnnotatorNotes T29	C0085590; catheter device; Medical Device
T30	LIVB 212 228	paciente crítico
#25	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group + C0815272; critical population; Population Group
T31	DEVI 430 437	catéter
#26	AnnotatorNotes T31	C0085590; catheter device; Medical Device
T32	LIVB 444 460	paciente crítico
#27	AnnotatorNotes T32	C0030705; Patients; Patient or Disabled Group + C0815272; critical population; Population Group
T33	DEVI 533 540	catéter
#28	AnnotatorNotes T33	C0085590; catheter device; Medical Device
T34	LIVB 575 584	Pacientes
#29	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T35	LIVB 606 615	Pacientes
#30	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	LIVB 665 674	Pacientes
#31	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T37	DEVI 701 723	catéter venoso central
#32	AnnotatorNotes T37	C1145640; Central venous catheter, device; Medical Device
T38	DEVI 725 728	CVC
#33	AnnotatorNotes T38	C1145640; Central venous catheter, device; Medical Device
T39	Duration 738 747	48h o más
T40	Spec_cue 939 954	probabilidad de
T41	CHEM 899 920	amarillo anaranjado S
#34	AnnotatorNotes T41	C0060120; Sunset Yellow FCF; Indicator, Reagent, or Diagnostic Aid · Organic Chemical
T42	Duration 972 979	las 48h
T43	DEVI 1003 1010	catéter
#35	AnnotatorNotes T43	C0085590; catheter device; Medical Device
T44	Dose 97 99	2%
T45	Dose 110 113	70%
T46	Dose 142 144	2%
T47	Dose 329 331	2%
T48	Dose 342 345	70%
T49	Dose 374 376	2%
T50	Age 638 661	mayor o igual a 18 años
T51	CHEM 922 926	E110
#36	AnnotatorNotes T51	C0060120; Sunset Yellow FCF; Indicator, Reagent, or Diagnostic Aid · Organic Chemical
A1	Assertion T23 Speculated
A2	Status T18 History_of
A3	Status T14 History_of
#37	AnnotatorNotes T25	C1579762; comparative study research; Research Activity + C0282462; Phase 4 Clinical Trials; Research Activity
#38	AnnotatorNotes T12	C1328352; Catheter bacteraemia; Disease or Syndrome
#39	AnnotatorNotes T9	C0007430; Catheterization; Therapeutic or Preventive Procedure | C0883301; Catheter placement; Therapeutic or Preventive Procedure
R1	Location_of Arg1:T2 Arg2:T1	
R2	Has_Dose_or_Strength Arg1:T3 Arg2:T44	
R3	Combined_with Arg1:T3 Arg2:T6	
R4	Has_Dose_or_Strength Arg1:T6 Arg2:T45	
R5	Used_for Arg1:T3 Arg2:T1	
R6	Used_for Arg1:T4 Arg2:T1	
R7	Has_Dose_or_Strength Arg1:T4 Arg2:T46	
R8	Experiences Arg1:T30 Arg2:T1	
R9	Experiences Arg1:T30 Arg2:T4	
R10	Experiences Arg1:T30 Arg2:T19	
R11	Overlap Arg1:T19 Arg2:T29	
R12	Before Arg1:T5 Arg2:T19	
R13	Experiences Arg1:T30 Arg2:T5	
R14	Used_for Arg1:T3 Arg2:T5	
R15	Used_for Arg1:T4 Arg2:T5	
T22	Quantifier_or_Qualifier 134 140	acuosa
#40	AnnotatorNotes T22	C0443350; Watery; Qualitative Concept
R16	Has_Quantifier_or_Qualifier Arg1:T4 Arg2:T22	
R17	Location_of Arg1:T27 Arg2:T26	
R18	Has_Dose_or_Strength Arg1:T20 Arg2:T47	
R19	Combined_with Arg1:T20 Arg2:T24	
R20	Has_Dose_or_Strength Arg1:T24 Arg2:T48	
R21	Used_for Arg1:T20 Arg2:T26	
R22	Used_for Arg1:T10 Arg2:T26	
R23	Used_for Arg1:T20 Arg2:T11	
R24	Used_for Arg1:T10 Arg2:T11	
R25	Has_Dose_or_Strength Arg1:T10 Arg2:T49	
T52	Quantifier_or_Qualifier 366 372	acuosa
#41	AnnotatorNotes T52	C0443350; Watery; Qualitative Concept
R26	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T52	
R27	Before Arg1:T11 Arg2:T21	
R28	Overlap Arg1:T21 Arg2:T31	
R29	Experiences Arg1:T32 Arg2:T21	
R30	Experiences Arg1:T32 Arg2:T11	
R31	Experiences Arg1:T32 Arg2:T26	
R32	Experiences Arg1:T32 Arg2:T10	
R33	Overlap Arg1:T33 Arg2:T8	
R34	Overlap Arg1:T12 Arg2:T33	
R35	Experiences Arg1:T34 Arg2:T13	
R36	Has_Age Arg1:T35 Arg2:T50	
T53	Quantifier_or_Qualifier 616 628	consecutivos
#42	AnnotatorNotes T53	C1707491; Consecutive; Qualitative Concept
R37	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T53	
T54	Quantifier_or_Qualifier 689 700	al menos un
R38	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T54	
R39	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T54	
R40	Has_Duration_or_Interval Arg1:T38 Arg2:T39	
R41	Has_Duration_or_Interval Arg1:T37 Arg2:T39	
R42	Experiences Arg1:T36 Arg2:T37	
R43	Experiences Arg1:T36 Arg2:T38	
R44	Causes Arg1:T15 Arg2:T18	
R45	Causes Arg1:T16 Arg2:T18	
R46	Causes Arg1:T41 Arg2:T18	
R47	Causes Arg1:T51 Arg2:T18	
R48	Causes Arg1:T15 Arg2:T14	
R49	Causes Arg1:T16 Arg2:T14	
R50	Causes Arg1:T41 Arg2:T14	
R51	Causes Arg1:T51 Arg2:T14	
R52	Speculation Arg1:T40 Arg2:T23	
R53	Overlap Arg1:T23 Arg2:T42	
R54	After Arg1:T23 Arg2:T17	
R55	Used_for Arg1:T43 Arg2:T9	
T55	Quantifier_or_Qualifier 931 938	Elevada
#43	AnnotatorNotes T55	C0205250; High; Qualitative Concept
R56	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T55	
T56	Quantifier_or_Qualifier 1011 1021	recubierto
#44	AnnotatorNotes T56	C5396449; Coated with material; Qualitative Concept
R57	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T56	
T57	Observation 1025 1059	Incluido previamente en el estudio
A4	Experiencer T30 Patient
A5	Experiencer T32 Patient
A6	Experiencer T34 Patient
A7	Experiencer T35 Patient
A8	Experiencer T36 Patient
